Marc N. Casper has been leading Thermo Fisher Scientific since October 2009. He climbed the company ladder starting as Senior Vice President in 2003, which gives him a deep understanding of the business. Marc has a Bachelor’s degree in Biology...

Current Market Cap

$194.34B

Number of Employees

122K

Total Compensation

2019 - 2023

Trending down by -36.54% last year
Showing total compensation for the last 2019 - 2023

Stock

Up by 0.00% last year

Salary

Up by 2.53% last year

Bonus

Down by -52.72% last year

Other

Down by -5.86% last year

Year

2023

Total Compensation

$5.08M

Salary

$1.73M

Board Justification

The compensation philosophy emphasizes performance-based pay that aligns with shareholder interests, with a significant portion of total compensation being at-risk and tied to financial and strategic performance metrics.

Bonus

$2.62M

Board Justification

The annual incentive plan paid out at 72.2% of target based on performance metrics including organic revenue growth, adjusted net income, and free cash flow, along with non-financial strategic measures.

Other

$730.24K

Board Justification

Includes matching contributions to the 401(k) plan, long-term disability insurance premiums, matching contributions to the non-qualified deferred compensation plan, dividends accrued on restricted stock units, personal security services, and non-business use of company aircraft.

Restricted Stock

$0.00(0 RSU)

Board Justification

No performance-based restricted stock units were vested in 2023 as the performance metrics were not met, resulting in cancellation of the awards.

Performance Metrics

The performance metrics for 2023 included organic revenue growth, adjusted net income, free cash flow, and non-financial strategic measures.

SEC Filing

From April 9, 2024